News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
212,699 Results
Type
Article (15072)
Company Profile (38)
Press Release (197589)
Section
Business (59550)
Career Advice (566)
Deals (8449)
Drug Delivery (37)
Drug Development (21165)
Employer Resources (42)
FDA (5382)
Job Trends (6049)
News (99453)
Policy (12825)
Tag
2024 BioCapital Digital (2)
2024 BioMidwest Digital (2)
2024 Bio NC Digital (3)
2024 Biotech Bay Standard (2)
2024 Biotech Beach Digital (1)
2024 Biotech Beach Standard (1)
2024 Genetown Standard (1)
2024 Lone Star Bio Digital (1)
2024 Pharm Country Standard (2)
2025 Lone Star Bio Digital (2)
2026 Pharm Country Standard (1)
Academia (1656)
Academic (1)
Adcomms (6)
Allergies (24)
Alliances (18272)
ALS (17)
Alzheimer's disease (494)
Antibody-drug conjugate (ADC) (19)
Approvals (5449)
Artificial intelligence (64)
Autoimmune disease (4)
Automation (8)
Bankruptcy (74)
Best Places to Work (5056)
BIOSECURE Act (14)
Biosimilars (28)
Biotechnology (24)
Bladder cancer (24)
Brain cancer (11)
Breast cancer (93)
Cancer (733)
Cardiovascular disease (42)
Career advice (486)
Career pathing (3)
CAR-T (38)
Cell therapy (91)
Cervical cancer (16)
Clinical research (16613)
Collaboration (257)
Compensation (9)
Complete response letters (3)
COVID-19 (1373)
CRISPR (11)
C-suite (52)
Cystic fibrosis (37)
Data (601)
Decentralized trials (1)
Denatured (1)
Depression (3)
Diabetes (62)
Diagnostics (3893)
Digital health (8)
Diversity (2)
Diversity, equity & inclusion (14)
Drug discovery (27)
Drug pricing (35)
Drug shortages (6)
Duchenne muscular dystrophy (26)
Earnings (15841)
Editorial (8)
Employer branding (5)
Employer resources (34)
Events (24622)
Executive appointments (182)
FDA (5768)
Featured Employer (9)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (2)
Frontotemporal dementia (4)
Funding (218)
Gene editing (14)
Generative AI (4)
Gene therapy (72)
GLP-1 (165)
Government (2771)
Grass and pollen (3)
Guidances (19)
Healthcare (8030)
IgA nephropathy (4)
Immunology and inflammation (12)
Indications (6)
Infectious disease (1428)
Inflammatory bowel disease (21)
Inflation Reduction Act (2)
Influenza (20)
Intellectual property (23)
Interviews (87)
IPO (3135)
IRA (12)
Job creations (1188)
Job search strategy (440)
Kidney cancer (4)
Labor market (7)
Layoffs (67)
Leadership (2)
Legal (2691)
Liver cancer (16)
Lung cancer (118)
Lymphoma (58)
Machine learning (3)
Management (12)
Manufacturing (92)
MASH (9)
Medical device (3050)
Medtech (3051)
Mergers & acquisitions (5414)
Metabolic disorders (111)
Multiple sclerosis (18)
NASH (1)
Neurodegenerative disease (19)
Neuropsychiatric disorders (1)
Neuroscience (599)
NextGen: Class of 2025 (2949)
Non-profit (3311)
Northern California (513)
Now hiring (16)
Obesity (41)
Opinion (51)
Ovarian cancer (11)
Pain (30)
Pancreatic cancer (16)
Parkinson's disease (27)
Partnered (8)
Patents (42)
Patient recruitment (28)
Peanut (13)
People (19952)
Pharmaceutical (9)
Pharmacy benefit managers (6)
Phase I (4720)
Phase II (6898)
Phase III (6219)
Pipeline (274)
Podcasts (5)
Policy (50)
Postmarket research (846)
Preclinical (2256)
Press Release (24)
Prostate cancer (42)
Psychedelics (3)
Radiopharmaceuticals (73)
Rare diseases (100)
Real estate (2803)
Recruiting (17)
Regulatory (8176)
Reports (12)
Research institute (1516)
Resumes & cover letters (72)
RSV (12)
Schizophrenia (15)
Series A (23)
Series B (17)
Service/supplier (2)
Sickle cell disease (16)
Southern California (504)
Special edition (2)
Spinal muscular atrophy (45)
Sponsored (12)
Startups (1059)
State (1)
Stomach cancer (3)
Supply chain (23)
The Weekly (3)
United States (5516)
Vaccines (228)
Venture capitalists (4)
Webinars (2)
Weight loss (29)
Women's health (10)
Worklife (1)
Date
Today (56)
Last 7 days (184)
Last 30 days (736)
Last 365 days (8883)
2025 (2036)
2024 (9335)
2023 (11032)
2022 (16126)
2021 (17939)
2020 (19087)
2019 (18204)
2018 (13729)
2017 (9688)
2016 (10386)
2015 (11399)
2014 (8903)
2013 (7472)
2012 (7915)
2011 (8423)
2010 (7150)
Location
Africa (304)
Alabama (16)
Alaska (3)
Arizona (74)
Arkansas (9)
Asia (13259)
Australia (2090)
California (1236)
Canada (542)
China (226)
Colorado (62)
Connecticut (67)
Delaware (49)
Europe (23551)
Florida (206)
Georgia (44)
Idaho (18)
Illinois (165)
India (12)
Indiana (84)
Iowa (3)
Japan (56)
Kansas (41)
Kentucky (12)
Louisiana (2)
Maine (24)
Maryland (345)
Massachusetts (711)
Michigan (75)
Minnesota (78)
Mississippi (2)
Missouri (58)
Montana (11)
Nebraska (7)
Nevada (24)
New Hampshire (17)
New Jersey (585)
New Mexico (15)
New York (419)
North Carolina (253)
North Dakota (1)
Northern California (513)
Ohio (57)
Oklahoma (5)
Oregon (9)
Pennsylvania (304)
Puerto Rico (1)
Rhode Island (14)
South America (370)
South Carolina (9)
South Dakota (1)
Southern California (504)
Tennessee (57)
Texas (265)
Utah (53)
Virginia (44)
Washington D.C. (17)
Washington State (138)
West Virginia (2)
Wisconsin (18)
212,699 Results for "oak ridge national laboratory".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Oklo Collaborates with the U.S. DOE and Oak Ridge National Laboratory to Advance Next Generation Materials Development
February 25, 2025
·
5 min read
Genetown
BPGbio Presents Key Advances in its Oncology Pipeline related to the NAi Interrogative Biology Platform
BPGbio, Inc. today announced the application of its NAi Interrogative Biology® Platform across several drug and diagnostic applications, following successful collaborations with Stanford University, University of Tennessee, Oak Ridge National Laboratory, and several leading hospitals across Mexico.
April 5, 2024
·
5 min read
Biosenta Announces Engagement of Oak Hill Financial Inc.
Biosenta Inc. (CSE: ZRO) (“Biosenta” or the “Company”) announces that it has entered into an agreement with Oak Hill Financial Inc. (“Oak Hill”) to provide business
January 11, 2024
·
3 min read
Policy
Hemostemix Announces Engagement of Oak Hill Asset Management Inc.
Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) (“Hemostemix” or the “Company”) is pleased to announce the non-exclusive engagement of Oak Hill Asset Management Inc. (“OHAM”), an Exempt Market Dealer to provide capital markets advice related to the Company’s capital markets strategy.
March 8, 2024
·
7 min read
Policy
ZEISS and Oak Ridge National Lab Align to Advance Characterization of Additively Manufactured Parts Using X-ray CT and Artificial Intelligence
Carl Zeiss Industrial Metrology, LLC has partnered with Oak Ridge National Laboratory on a project chosen to receive funding through the U.S. Department of Energy’s Technology Commercialization Fund project solicitation.
August 16, 2021
·
7 min read
Lone Star Bio
Sterling Ridge Orthopaedic & Sports Medicine Sets Milestone with Dr. Paul Chin’s Innovative Shoulder Replacement Surgery
Sterling Ridge Orthopaedics & Sports Medicine proudly announces a groundbreaking achievement in orthopaedic surgery with Dr. Paul Chin, MD, PhD, FAAOS, FAANA, at the forefront.
May 2, 2024
·
2 min read
Press Releases
Oak Hill Bio Announces Promotion of Josh Distler to Chief Executive Officer and Additional Updates to Executive Team and Board
October 7, 2024
·
5 min read
Drug Development
Oak Hill Bio and Chiesi Group Announce First Patient Enrolled in the Resumed Phase 2b Clinical Study Evaluating OHB-607 for the Prevention of Bronchopulmonary Dysplasia, the Most Common Cause of Chronic Lung Disease in Premature Infants
Oak Hill Bio and Chiesi announced that the first patient has been enrolled in a resumed Phase 2b clinical study to assess the efficacy and safety of OHB-607, an investigational drug candidate being developed to treat complications of extremely premature birth, including bronchopulmonary dysplasia, a serious condition for which there are no approved therapies.
May 17, 2024
·
4 min read
Press Releases
Pierre Fabre Laboratories and RedRidge Bio Announce a Drug Discovery and Co-development Partnership
March 12, 2025
·
2 min read
BioMidwest
Cummins Inc. and Oak Ridge National Laboratory Collaboration Enables Capability to Produce Millions of Face Masks
A collaboration between Cummins Inc. and the Carbon Fiber Technology Facility at the Department of Energy’s Oak Ridge National Laboratory has resulted in the ability to produce enough filter media to supply more than a million face masks and respirators per day to U.S. healthcare facilities.
September 3, 2020
·
5 min read
1 of 21,270
Next